41 related articles for article (PubMed ID: 33506275)
1. Paynantheine more effectively reverses multidrug resistance in malignant EPG85.257RDB and MCF7MX cells than morphine and speciociliatine.
Abdali N; Nadipour Borujeni M; Hosseini SA; Malekzadeh R; Abolhasani M; Mirzaei SA; Elahian F
Cell Biol Int; 2024 Jun; 48(6):861-871. PubMed ID: 38480672
[TBL] [Abstract][Full Text] [Related]
2. Factors Influencing Mortality in Children with Central Nervous System Tumors: A Cohort Study on Clinical Characteristics and Genetic Markers.
Torres-Espíndola LM; Pérez-De Marcos JC; Castillejos-López M; Velasco-Hidalgo L; Cárdenas-Cardós R; De Uña-Flores A; Salinas-Lara C; Caballero-Salazar S; Fernández-Plata R; Aquíno-Gálvez A
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674407
[TBL] [Abstract][Full Text] [Related]
3. Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer.
McCorkle JR; Gorski JW; Liu J; Riggs MB; McDowell AB; Lin N; Wang C; Ueland FR; Kolesar JM
PLoS One; 2021; 16(8):e0254205. PubMed ID: 34347777
[TBL] [Abstract][Full Text] [Related]
4. Adipocyte‑rich microenvironment promotes chemoresistance via upregulation of peroxisome proliferator‑activated receptor gamma/ABCG2 in epithelial ovarian cancer.
Chen S; Liu Z; Wu H; Wang B; Ouyang Y; Liu J; Zheng X; Zhang H; Li X; Feng X; Li Y; Shen Y; Zhang H; Xiao B; Yu C; Deng W
Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38426604
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP).
Rigalli JP; Gagliardi A; Diester K; Bajraktari-Sylejmani G; Blank A; Burhenne J; Lenard A; Werntz L; Huppertz A; Münch L; Wendt JM; Sauter M; Haefeli WE; Weiss J
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612927
[TBL] [Abstract][Full Text] [Related]
6. Rare Variants in the
Eclov RJ; Kim MJ; Smith R; Ahituv N; Kroetz DL
Drug Metab Dispos; 2018 May; 46(5):636-642. PubMed ID: 29467213
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance.
Liu C; Billet S; Choudhury D; Cheng R; Haldar S; Fernandez A; Biondi S; Liu Z; Zhou H; Bhowmick NA
Neoplasia; 2021 Jan; 23(1):118-128. PubMed ID: 33310208
[TBL] [Abstract][Full Text] [Related]
8. Significance of ATP-binding cassette transporter proteins in multidrug resistance of head and neck squamous cell carcinoma.
Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
Oncol Lett; 2015 Aug; 10(2):631-636. PubMed ID: 26622545
[TBL] [Abstract][Full Text] [Related]
9. A novel ABCG2 variant causing Jr(a-) phenotype.
Kwon SS; Yun YE; Kim NH; Suh EJ; Kim SK; Kim S
Transfusion; 2024 Apr; 64(4):E9-E10. PubMed ID: 38361420
[No Abstract] [Full Text] [Related]
10. Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells.
Sanchez Y; Vasquez Callejas MA; Miret NV; Rolandelli G; Costas C; Randi AS; Español A
Explor Target Antitumor Ther; 2024; 5(2):278-295. PubMed ID: 38745771
[TBL] [Abstract][Full Text] [Related]
11. New Insights into Chemoresistance Mediated by Mdm2 Inhibitors: The Benefits of Targeted Therapy over Common Cytostatics.
Grigoreva T; Sagaidak A; Novikova D; Tribulovich V
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540160
[TBL] [Abstract][Full Text] [Related]
12. SLC20A1 is a prospective prognostic and therapy response predictive biomarker in head and neck squamous cell carcinoma.
Qian X; Jin M; Bei Y; Zhou C; Fang S; Liu K
Aging (Albany NY); 2024 Feb; 16(5):4423-4444. PubMed ID: 38412319
[TBL] [Abstract][Full Text] [Related]
13. Exposure to anticancer drugs modulates the expression of ACSL4 and ABCG2 proteins in adrenocortical carcinoma cells.
Ríos Medrano MA; Bigi MM; Martínez Ponce P; Podesta EJ; Orlando UD
Heliyon; 2023 Oct; 9(10):e20769. PubMed ID: 37867801
[TBL] [Abstract][Full Text] [Related]
14. The role of the stemness index-associated signature in the analysis of the tumorigenesis of liver cancer patients of different races.
Liu DH; Wen GM; Song CL; Xu ZJ; Ren F; Zhao ZY; Xia P
Am J Cancer Res; 2023; 13(3):802-817. PubMed ID: 37034207
[TBL] [Abstract][Full Text] [Related]
15. Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells.
Español A; Sanchez Y; Salem A; Obregon J; Sales ME
World J Clin Oncol; 2022 Jun; 13(6):505-519. PubMed ID: 35949430
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Butyrate-Resistant Colorectal Cancer Cell Lines and the Cytotoxicity of Anticancer Drugs against These Cells.
Nittayaboon K; Leetanaporn K; Sangkhathat S; Roytrakul S; Navakanitworakul R
Biomed Res Int; 2022; 2022():6565300. PubMed ID: 35909471
[TBL] [Abstract][Full Text] [Related]
17. Feature screening for survival trait with application to TCGA high-dimensional genomic data.
Wang JH; Li CR; Hou PL
PeerJ; 2022; 10():e13098. PubMed ID: 35291482
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of ABCB1, ABCG2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells.
Duz MB; Karatas OF
Mol Biol Rep; 2021 Feb; 48(2):1393-1400. PubMed ID: 33506275
[TBL] [Abstract][Full Text] [Related]
19. Expression profile of stem cell markers and ABC transporters in 5-fluorouracil resistant Hep-2 cells.
Duz MB; Karatas OF
Mol Biol Rep; 2020 Jul; 47(7):5431-5438. PubMed ID: 32627138
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
